{"schema_version":"1","generated_at":"2026-10-28T01:49:01.500Z","data_as_of":"2026-10-26","url":"https://www.findmykol.com/kol/igor-barani","json_url":"https://www.findmykol.com/kol/igor-barani/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"igor-barani","name":"Igor Barani","credential":"MD","title":"Chair, Department of Radiation Oncology, Barrow Neurological Institute (also listed as Chief, Stereotactic Radiosurgery)","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Neuro-Oncology","therapeutic_areas":["Neuro-Oncology"],"institution":"Barrow Neurological Institute","institution_url":"https://www.findmykol.com/institution/barrow-neurological-institute","city":"Phoenix","state":"AZ","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1811105943","orcid":"0000-0002-8256-1906","openalex":"A5109374295"},"summary":"Igor Barani is Chair, Department of Radiation Oncology, Barrow Neurological Institute (also listed as Chief, Stereotactic Radiosurgery) at Barrow Neurological Institute. OpenAlex indexes 176 publications with 7,173 citations (h-index 43); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.","overview":{"text":"Igor Barani, MD, is Chair, Department of Radiation Oncology, Barrow Neurological Institute (also listed as Chief, Stereotactic Radiosurgery). The public record shows 176 publications with 7,173 citations (h-index 43), centered on Glioma Diagnosis and Treatment, Advanced Radiotherapy Techniques, Brain Metastases and Treatment. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies.","bullets":["Top research focus: Glioma Diagnosis and Treatment","3 registered trials on ClinicalTrials.gov","Open Payments reporting from 3 companies"],"generated_at":"2026-10-27"},"focus":{"indications":[{"label":"Neoplasm Metastasis","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Brain Neoplasms","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4}],"research_topics":["Glioma Diagnosis and Treatment","Advanced Radiotherapy Techniques","Brain Metastases and Treatment","Meningioma and schwannoma management","Radiation Therapy and Dosimetry"],"works_with":{"total":5,"shown":3,"withheld":2,"rows":[{"name":"Zap Surgical Systems, Inc.","trials":0,"payments":3,"mentions":3},{"name":"Brainlab, Inc.","trials":0,"payments":2,"mentions":2},{"name":"University of California, San Francisco","trials":2,"payments":0,"mentions":2}]}},"scholarship":{"works_count":176,"cited_by_count":7173,"h_index":43,"i10_index":76,"pubmed_count":3,"latest_activity_year":2023,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT04840069","title":"Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE2","status":"UNKNOWN","role":"Investigator","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","source_url":"https://clinicaltrials.gov/study/NCT04840069","trial_url":"https://www.findmykol.com/trial/NCT04840069"},{"nct":"NCT01821443","title":"A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)","phase":"NA","status":"TERMINATED","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT01821443","trial_url":"https://www.findmykol.com/trial/NCT01821443"},{"nct":"NCT01731704","title":"Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases","phase":"NA","status":"WITHDRAWN","role":"Investigator","sponsor":"University of California, San Francisco","source_url":"https://clinicaltrials.gov/study/NCT01731704","trial_url":"https://www.findmykol.com/trial/NCT01731704"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":2023},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Zap Surgical Systems, Inc.","program_year":2023,"amount_usd":127.24,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811105943"},{"payer":"Brainlab, Inc.","program_year":2023,"amount_usd":77.37,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811105943"},{"payer":"Siemens Medical Solutions USA, Inc.","program_year":2023,"amount_usd":27.42,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811105943"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1811105943","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":33,"years":{"first":2006,"last":2026},"societies":["AACR","ASCO","ASTRO","ESMO"],"shown":3,"withheld":30,"rows":[{"title":"Change in relative cerebral blood volume as a biomarker for early response to bevacizumab in patients with recurrent glioblastoma: ECOG-ACRIN EAF151.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.2016","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.2016","status":"verified"},{"title":"Abstract 2513: Factors influencing participant attrition in Phase 0 hybrid clinical trials for patients with high-grade glioma","society":"AACR","meeting":"AACR Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2025-2513","source_url":"https://doi.org/10.1158/1538-7445.am2025-2513","status":"verified"},{"title":"Abstract CT125: A phase 0/2 ‘trigger’ trial of pamiparib or olaparib plus radiotherapy in patients with newly-diagnosed or recurrent glioblastoma","society":"AACR","meeting":"AACR Annual Meeting","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2024-ct125","source_url":"https://doi.org/10.1158/1538-7445.am2024-ct125","status":"verified"}],"source":"congress"},"publications":{"total":3,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","year":2023,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(23)00147-x","status":"verified"},{"title":"Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539","year":2022,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noac137","status":"verified"},{"title":"Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424","year":2020,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2020.03.027","status":"verified"},{"title":"Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma","year":2017,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2017.06.2466","status":"verified"},{"title":"Surgery After Primary Radiation Treatment for Sporadic Vestibular Schwannomas: Case Series","year":2017,"journal":"Operative Neurosurgery","source_url":"https://doi.org/10.1093/ons/opx023","status":"verified"}],"most_cited":{"total":176,"shown":5,"withheld":171,"rows":[{"title":"Response assessment criteria for brain metastases: proposal from the RANO group","year":2015,"cited_by_count":1093,"type":"article","source_url":"https://doi.org/10.1016/s1470-2045(15)70057-4"},{"title":"Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review","year":2014,"cited_by_count":700,"type":"article","source_url":"https://doi.org/10.3171/2014.7.jns131644"},{"title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","year":2014,"cited_by_count":270,"type":"article","source_url":"https://doi.org/10.1093/neuonc/not330"},{"title":"Relationship of glioblastoma multiforme to the subventricular zone is associated with survival","year":2012,"cited_by_count":212,"type":"article","source_url":"https://doi.org/10.1093/neuonc/nos268"},{"title":"Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial","year":2023,"cited_by_count":207,"type":"article","source_url":"https://doi.org/10.1016/s1470-2045(23)00147-x"}]},"source":"works"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Penny K. Sneed","coauthored_works":28},{"name":"David Allen Larson","coauthored_works":27},{"name":"Lijun Ma","coauthored_works":27,"profile_url":"https://www.findmykol.com/kol/lijun-ma"}],"source":"works"},"presence":{"mentions":{"total":1,"shown":1,"rows":[{"url":"https://barrowneuro.org/person/igor-barani-md/","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"Residency, Virginia Commonwealth University School of Medicine, Radiation Oncology, 2004-2008","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"MD, State University of New York Upstate Medical University, College of Medicine, 2003","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Research Fellowship, Howard Hughes Medical Institute, 2000-2001","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Board certified in radiation oncology by the American Board of Radiology","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"}]},"roles":{"total":4,"shown":3,"rows":[{"value":"Member, American Society for Radiation Oncology","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Member, Society for Neuro-Oncology","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Member, American Society of Clinical Oncology","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"}]},"awards":{"total":3,"shown":3,"rows":[{"value":"Board Examiner, American Board of Radiology (2015)","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Top Doctor, Castle Connolly (2014)","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Lawrence Margolis Lifetime Teaching Award, University of California, San Francisco, Department of Radiation Oncology (2009)","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"}]},"secondary_affiliations":{"total":4,"shown":3,"rows":[{"value":"University of California, San Francisco, Department of Radiation Oncology (past faculty, vice-chair and director of clinical research, 2010-2015)","source_url":"https://orcid.org/0000-0002-8256-1906","status":"verified","collected_at":"2026-10-26"},{"value":"Barrow Artificial Intelligence Center (director)","source_url":"https://www.barrowneuro.org/person/igor-barani-md/","status":"verified","collected_at":"2026-10-26"},{"value":"Enlitic, Inc. (past, Chief Executive Officer and Chief Medical Officer)","source_url":"https://orcid.org/0000-0002-8256-1906","status":"verified","collected_at":"2026-10-26"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Quoted on ZAP-X radiosurgery platform launch at Barrow Brain and Spine (2019 press release)","source_url":"https://barrowbrainandspine.com/blog/newsroom/barrow-brain-spine-zap-x-non-invasive-radiosurgery/","status":"provisional","collected_at":"2026-10-26"}]}},"similar":[{"name":"Marwan Sabbagh","slug":"marwan-sabbagh","institution":"Barrow Neurological Institute","specialty":"Neurology","url":"https://www.findmykol.com/kol/marwan-sabbagh","json_url":"https://www.findmykol.com/kol/marwan-sabbagh/profile.json"},{"name":"Jeremy Shefner","slug":"jeremy-shefner","institution":"Barrow Neurological Institute","specialty":"Neurology","url":"https://www.findmykol.com/kol/jeremy-shefner","json_url":"https://www.findmykol.com/kol/jeremy-shefner/profile.json"},{"name":"Shafeeq Ladha","slug":"shafeeq-ladha","institution":"Barrow Neurological Institute","specialty":"Neuromuscular Medicine","url":"https://www.findmykol.com/kol/shafeeq-ladha","json_url":"https://www.findmykol.com/kol/shafeeq-ladha/profile.json"},{"name":"Michael Lawton","slug":"michael-lawton","institution":"Barrow Neurological Institute","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/michael-lawton","json_url":"https://www.findmykol.com/kol/michael-lawton/profile.json"},{"name":"Guy McKhann","slug":"guy-mckhann","institution":"Emory University School of Medicine","specialty":"Neurological Surgery","url":"https://www.findmykol.com/kol/guy-mckhann","json_url":"https://www.findmykol.com/kol/guy-mckhann/profile.json"},{"name":"Patrick Wen","slug":"patrick-wen","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/patrick-wen","json_url":"https://www.findmykol.com/kol/patrick-wen/profile.json"},{"name":"Minesh Mehta","slug":"minesh-mehta","institution":"Florida International University Herbert Wertheim College of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/minesh-mehta","json_url":"https://www.findmykol.com/kol/minesh-mehta/profile.json"},{"name":"Timothy Cloughesy","slug":"timothy-cloughesy","institution":"Ronald Reagan UCLA Medical Center","specialty":"Neurology","url":"https://www.findmykol.com/kol/timothy-cloughesy","json_url":"https://www.findmykol.com/kol/timothy-cloughesy/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"congress":30,"publications":45,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-26"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-26"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2023","collected_at":"2026-10-26"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-26"}},"methodology_url":"https://www.findmykol.com/about#methodology"}